E, B., WW, T., KM, V., MP, Y., N, S., Y, J., . . . S, S. (2018). Synergism between the tyrosine kinase inhibitor sunitinib and Anti-TNF antibody protects against lethal dengue infection. Antiviral research, 158, 1. https://doi.org/10.1016/j.antiviral.2018.07.022
Chicago Style (17th ed.) CitationE, Branche, Tang WW, Viramontes KM, Young MP, Sheets N, Joo Y, Nguyen AT, and Shresta S. "Synergism Between the Tyrosine Kinase Inhibitor Sunitinib and Anti-TNF Antibody Protects Against Lethal Dengue Infection." Antiviral Research 158 (2018): 1. https://doi.org/10.1016/j.antiviral.2018.07.022.
MLA (9th ed.) CitationE, Branche, et al. "Synergism Between the Tyrosine Kinase Inhibitor Sunitinib and Anti-TNF Antibody Protects Against Lethal Dengue Infection." Antiviral Research, vol. 158, 2018, p. 1, https://doi.org/10.1016/j.antiviral.2018.07.022.